TICE BCG (BCG live)
BCG · MALIGNANT TUMOR OF URINARY BLADDER ·+1
Merck Sharp & Dohme
Drug class
BCG
Bacillus Calmette-Guérin (BCG) refers to a specific biological agent derived from live-attenuated Mycobacterium bovis rather than a broad, multi-drug therapeutic class. Read more about BCG
3 drugs in this class 1 manufacturers
Drugs in BCG
BCG (TICE STRAIN) (BCG live)
BCG · MALIGNANT TUMOR OF URINARY BLADDER ·+1
Merck Sharp & Dohme
BCG VACCINE (TICE STRAIN) (BCG vaccine, live/PF)
BCG · TUBERCULOSIS PROPHYLAXIS
Merck Sharp & Dohme
Filter & compare in the drug finder →
Opens the drug finder with BCG preselected. Add indication or manufacturer filters there.
Bacillus Calmette-Guérin (BCG) refers to a specific biological agent derived from live-attenuated Mycobacterium bovis rather than a broad, multi-drug therapeutic class.
Clinically, it functions as an immunomodulatory agent, vaccine, and biological response modifier.
Administered intravesically, BCG triggers an intense local inflammatory response and cell-mediated immune activation that eliminates residual malignant cells and prevents recurrence in non-muscle-invasive bladder cancer, specifically carcinoma in situ and high-grade papillary tumors.
In global public health, it is administered percutaneously or intradermally as an active immunization agent to stimulate protective adaptive immunity against tuberculosis in high-risk populations.
-
fda.gov
Bacillus Calmette-Guérin (BCG) refers to a specific biological agent derived from live-attenuated Mycobacterium bovis rather than a broad, multi-drug therapeutic class Administered intravesically, BCG triggers an intense local inflammatory response and cell-mediated immune activation that eliminates residual malignant cells and prevents recurrence in non-muscle-invasive bladder cancer, specifically carcinoma in situ and high-grade papillary tumors
-
nih.gov
Bacillus Calmette-Guérin (BCG) refers to a specific biological agent derived from live-attenuated Mycobacterium bovis rather than a broad, multi-drug therapeutic class In global public health, it is administered percutaneously or intradermally as an active immunization agent to stimulate protective adaptive immunity against tuberculosis in high-risk populations
-
nih.gov
Clinically, it functions as an immunomodulatory agent, vaccine, and biological response modifier
-
mims.com
Clinically, it functions as an immunomodulatory agent, vaccine, and biological response modifier
-
clevelandclinic.org
Administered intravesically, BCG triggers an intense local inflammatory response and cell-mediated immune activation that eliminates residual malignant cells and prevents recurrence in non-muscle-invasive bladder cancer, specifically carcinoma in situ and high-grade papillary tumors
-
fda.gov
In global public health, it is administered percutaneously or intradermally as an active immunization agent to stimulate protective adaptive immunity against tuberculosis in high-risk populations
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.